Published in Mov Disord on October 15, 2010
Neurorehabilitation of Sequence Effect in Parkinson's Disease | NCT04921748
Hypokinesia without decrement distinguishes progressive supranuclear palsy from Parkinson's disease. Brain (2012) 1.08
Milestones in clinical neurophysiology. Mov Disord (2011) 0.86
Vascular Parkinsonism: deconstructing a syndrome. Mov Disord (2015) 0.85
Neural correlates underlying micrographia in Parkinson's disease. Brain (2015) 0.79
Safety of transcranial magnetic stimulation in Parkinson's disease: a review of the literature. Parkinsonism Relat Disord (2013) 0.77
Handwriting Rehabilitation in Parkinson Disease: A Pilot Study. Ann Rehabil Med (2015) 0.75
Sequence Effect in Parkinson's Disease Is Related to Motor Energetic Cost. Front Neurol (2016) 0.75
The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia (1971) 86.03
Randomized controlled trial of intraputamenal glial cell line-derived neurotrophic factor infusion in Parkinson disease. Ann Neurol (2006) 5.49
Functional role of the supplementary and pre-supplementary motor areas. Nat Rev Neurosci (2008) 5.20
Compulsive drug use linked to sensitized ventral striatal dopamine transmission. Ann Neurol (2006) 2.56
Disturbance of sequential movements in patients with Parkinson's disease. Brain (1987) 2.30
Pathophysiology of bradykinesia in Parkinson's disease. Brain (2001) 2.24
Therapeutic application of repetitive transcranial magnetic stimulation: a review. Clin Neurophysiol (2001) 2.14
Role for supplementary motor area cells in planning several movements ahead. Nature (1994) 2.13
A functional MRI study of automatic movements in patients with Parkinson's disease. Brain (2005) 2.09
Testing objective measures of motor impairment in early Parkinson's disease: Feasibility study of an at-home testing device. Mov Disord (2009) 2.00
Nonmotor fluctuations in Parkinson's disease: frequent and disabling. Neurology (2002) 1.96
Asymmetry in the human motor cortex and handedness. Neuroimage (1996) 1.94
Reaction time in Parkinson's disease. Brain (1981) 1.92
Scaling of the size of the first agonist EMG burst during rapid wrist movements in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry (1986) 1.88
Fatigue and basal ganglia. J Neurol Sci (2000) 1.82
Striatal dopamine release induced by repetitive transcranial magnetic stimulation of the human motor cortex. Brain (2003) 1.66
Zonisamide improves motor function in Parkinson disease: a randomized, double-blind study. Neurology (2007) 1.65
The sequence effect and gait festination in Parkinson disease: contributors to freezing of gait? Mov Disord (2006) 1.58
Function of the basal ganglia as revealed by cognitive and motor disorders in Parkinson's disease. Can J Neurol Sci (1984) 1.58
Motor cortex plasticity in Parkinson's disease and levodopa-induced dyskinesias. Brain (2006) 1.53
Fatigue in Parkinson's disease: a review. Mov Disord (2007) 1.53
Sequential arm movements in patients with Parkinson's disease, Huntington's disease and dystonia. Brain (1992) 1.48
Lateralization of motor circuits and handedness during finger movements. Eur J Neurol (2001) 1.48
Different functional loops between cerebral cortex and the subthalmic area in Parkinson's disease. Cereb Cortex (2005) 1.46
Distinguishing sleepiness and fatigue: focus on definition and measurement. Sleep Med Rev (2005) 1.46
Slow oscillatory activity and levodopa-induced dyskinesias in Parkinson's disease. Brain (2006) 1.43
Long-term follow-up of unilateral pallidotomy in advanced Parkinson's disease. N Engl J Med (2000) 1.32
Placebo-controlled study of rTMS for the treatment of Parkinson's disease. Mov Disord (2006) 1.26
Fatigue in patients with Parkinson's disease. Mov Disord (1999) 1.21
Akinesia in Parkinson's disease. Neurology (1959) 1.18
Akinesia in Parkinson's disease. II. Effects of subthreshold repetitive transcranial motor cortex stimulation. Neurology (1994) 1.18
Corticostriatal functional interactions in Parkinson's disease: a rTMS/[11C]raclopride PET study. Eur J Neurosci (2005) 1.17
Effect of daily repetitive transcranial magnetic stimulation on motor performance in Parkinson's disease. Mov Disord (2006) 1.16
Fatigue in levodopa-naive subjects with Parkinson disease. Neurology (2008) 1.13
The comparable size and overlapping nature of upper limb distal and proximal muscle representations in the human motor cortex. Eur J Neurosci (2006) 1.11
Repetitive transcranial magnetic stimulation is as effective as fluoxetine in the treatment of depression in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry (2004) 1.10
Cortical inhibition in Parkinson's disease. A study with paired magnetic stimulation. Brain (1996) 1.06
Provision of external cues and movement sequencing in Parkinson's disease. Motor Control (1998) 1.02
The basal ganglia network mediates the planning of movement amplitude. Eur J Neurosci (2004) 1.02
Compensatory cortical mechanisms in Parkinson's disease evidenced with fMRI during the performance of pre-learned sequential movements. Brain Res (2007) 1.00
The effect of withdrawal of dopaminergic medication on simple and choice reaction time and the use of advance information in Parkinson's disease. J Neurol Neurosurg Psychiatry (1992) 0.98
Repetitive transcranial magnetic stimulation. The International Federation of Clinical Neurophysiology. Electroencephalogr Clin Neurophysiol Suppl (1999) 0.92
A quantitative evaluation of the effects of L-dopa on Parkinson's disease. Neuropharmacology (1973) 0.90
Repetitive transcranial magnetic stimulation (rTMS): insights into the treatment of Parkinson's disease by cortical stimulation. Neurophysiol Clin (2006) 0.88
Fast complex arm movements in Parkinson's disease. J Neurol Neurosurg Psychiatry (1986) 0.88
Long-term effect of motor cortical repetitive transcranial magnetic stimulation [correction]. Ann Neurol (2004) 0.86
Modulation of motor cortical excitability following rapid-rate transcranial magnetic stimulation. Clin Neurophysiol (2006) 0.85
Analysis of repetitive and nonrepetitive sequential arm movements in patients with Parkinson's disease. Mov Disord (1994) 0.85
Long-term follow-up study with repetitive transcranial magnetic stimulation (rTMS) in Parkinson's disease. Brain Res Bull (2004) 0.84
Pallidal deep brain stimulation and L-dopa do not improve qualitative aspects of skilled reaching in Parkinson's disease. Behav Brain Res (2005) 0.84
Finger tapping, handedness and grey matter amount in the Rolando's genu area. Neuroimage (2005) 0.84
Future directions in the treatment of Parkinson's disease. Mov Disord (2007) 0.82
Effects of pallidotomy and levodopa on walking and reaching movements in Parkinson's disease. Mov Disord (2003) 0.81
Hand coordination as a quantitative measure of motor abnormality and therapeutic response in Parkinson's disease. Clin Neurophysiol (2007) 0.80
The role of hand dominance and sensorimotor congruence in voluntary movement. Exp Brain Res (2009) 0.78
Akinesia and the frontal lobe. Clin EEG Neurosci (2008) 0.77
Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research. Clin Neurophysiol (2009) 11.59
Phenomenology and classification of dystonia: a consensus update. Mov Disord (2013) 4.98
Identifying true brain interaction from EEG data using the imaginary part of coherency. Clin Neurophysiol (2004) 4.19
Early consolidation in human primary motor cortex. Nature (2002) 3.56
The pathophysiological basis of dystonias. Nat Rev Neurosci (2008) 3.46
Modeling the current distribution during transcranial direct current stimulation. Clin Neurophysiol (2006) 3.39
Criteria for the diagnosis of corticobasal degeneration. Neurology (2013) 3.07
The cerebellum in Parkinson's disease. Brain (2013) 3.06
What is the Bereitschaftspotential? Clin Neurophysiol (2006) 3.02
Classification and definition of disorders causing hypertonia in childhood. Pediatrics (2003) 2.93
Levodopa in the treatment of Parkinson's disease: current controversies. Mov Disord (2004) 2.90
Scale to predict survival after surgery for recurrent glioblastoma multiforme. J Clin Oncol (2010) 2.67
Freezing of gait: moving forward on a mysterious clinical phenomenon. Lancet Neurol (2011) 2.65
Repetitive transcranial magnetic stimulation-induced corticomotor excitability and associated motor skill acquisition in chronic stroke. Stroke (2006) 2.63
Regional homogeneity changes in patients with Parkinson's disease. Hum Brain Mapp (2009) 2.42
Efficacy and safety of dutasteride in patients with spinal and bulbar muscular atrophy: a randomised placebo-controlled trial. Lancet Neurol (2011) 2.27
What does the ratio of injected current to electrode area tell us about current density in the brain during tDCS? Clin Neurophysiol (2009) 2.17
Transcranial magnetic stimulation of the brain: guidelines for pain treatment research. Pain (2015) 2.11
A functional MRI study of automatic movements in patients with Parkinson's disease. Brain (2005) 2.09
Emotional stimuli and motor conversion disorder. Brain (2010) 2.06
Multimodal imaging of brain reorganization in motor areas of the contralesional hemisphere of well recovered patients after capsular stroke. Brain (2005) 2.03
Psychopathology and psychogenic movement disorders. Mov Disord (2011) 2.02
Testing objective measures of motor impairment in early Parkinson's disease: Feasibility study of an at-home testing device. Mov Disord (2009) 2.00
Cerebral causes and consequences of parkinsonian resting tremor: a tale of two circuits? Brain (2012) 1.99
Improving hand function in chronic stroke. Arch Neurol (2002) 1.95
How self-initiated memorized movements become automatic: a functional MRI study. J Neurophysiol (2003) 1.93
Levels of alpha-synuclein mRNA in sporadic Parkinson disease patients. Mov Disord (2006) 1.93
Transcranial direct current stimulation for the treatment of Parkinson's disease. J Neurol Neurosurg Psychiatry (2010) 1.93
Effects of aging on the human motor cortical plasticity studied by paired associative stimulation. Clin Neurophysiol (2009) 1.89
The spectrum of parkinsonian manifestations associated with glucocerebrosidase mutations. Arch Neurol (2008) 1.87
Functional properties of brain areas associated with motor execution and imagery. J Neurophysiol (2003) 1.86
Mechanisms underlying dopamine-mediated reward bias in compulsive behaviors. Neuron (2010) 1.85
Constraint-induced therapy in stroke: magnetic-stimulation motor maps and cerebral activation. Neurorehabil Neural Repair (2003) 1.83
Do primary adult-onset focal dystonias share aetiological factors? Brain (2007) 1.83
Reciprocal alterations in pre- and postsynaptic inhibitory markers at chandelier cell inputs to pyramidal neurons in schizophrenia. Cereb Cortex (2002) 1.77
Clinical features of spinal and bulbar muscular atrophy. Brain (2009) 1.75
Protein SUMOylation is massively increased in hibernation torpor and is critical for the cytoprotection provided by ischemic preconditioning and hypothermia in SHSY5Y cells. J Cereb Blood Flow Metab (2006) 1.75
Motor planning, imagery, and execution in the distributed motor network: a time-course study with functional MRI. Cereb Cortex (2008) 1.72
Increased midbrain gray matter in Tourette's syndrome. Ann Neurol (2006) 1.69
Movement-related cortical stimulation can induce human motor plasticity. J Neurosci (2010) 1.68
Virtual reality-induced cortical reorganization and associated locomotor recovery in chronic stroke: an experimenter-blind randomized study. Stroke (2005) 1.68
Higher anticipated force required a stronger inhibitory process in go/nogo tasks. Clin Neurophysiol (2006) 1.66
Impulsive choice and response in dopamine agonist-related impulse control behaviors. Psychopharmacology (Berl) (2009) 1.62
The focal dystonias: current views and challenges for future research. Mov Disord (2013) 1.62
Residual brain dysfunction observed one year post-mild traumatic brain injury: combined EEG and balance study. Clin Neurophysiol (2012) 1.55
Reduced pyramidal cell somal volume in auditory association cortex of subjects with schizophrenia. Neuropsychopharmacology (2002) 1.55
Effective transvascular delivery of nanoparticles across the blood-brain tumor barrier into malignant glioma cells. J Transl Med (2008) 1.54
Transcranial magnetic stimulation of deep brain regions: evidence for efficacy of the H-coil. Clin Neurophysiol (2004) 1.54
Consensus paper: combining transcranial stimulation with neuroimaging. Brain Stimul (2009) 1.54
Metabolic alterations in corpus callosum may compromise brain functional connectivity in MTBI patients: an 1H-MRS study. Neurosci Lett (2011) 1.51
Repetitive transcranial magnetic stimulation or transcranial direct current stimulation? Brain Stimul (2009) 1.49
Contribution of the ipsilateral motor cortex to recovery after chronic stroke. Ann Neurol (2003) 1.48
What we think before a voluntary movement. J Cogn Neurosci (2013) 1.48
Alteration of brain default network in subacute phase of injury in concussed individuals: resting-state fMRI study. Neuroimage (2011) 1.48
Neural correlates of cross-modal binding. Nat Neurosci (2003) 1.48
Psychiatric symptoms associated with focal hand dystonia. Mov Disord (2010) 1.47
Validation of digital spiral analysis as outcome parameter for clinical trials in essential tremor. Mov Disord (2011) 1.47
Surround inhibition in human motor system. Exp Brain Res (2004) 1.45
Linear and nonlinear information flow based on time-delayed mutual information method and its application to corticomuscular interaction. Clin Neurophysiol (2009) 1.45
Emerging concepts in the physiological basis of dystonia. Mov Disord (2013) 1.45
The non-motor syndrome of primary dystonia: clinical and pathophysiological implications. Brain (2011) 1.44
Effective connectivity of brain networks during self-initiated movement in Parkinson's disease. Neuroimage (2010) 1.44
Disturbed surround inhibition in focal hand dystonia. Ann Neurol (2004) 1.43
Focal white matter changes in spasmodic dysphonia: a combined diffusion tensor imaging and neuropathological study. Brain (2007) 1.40
The influence of normal human ageing on automatic movements. J Physiol (2004) 1.40
Kinematic improvement following Botulinum Toxin-A injection in upper-limb spasticity due to stroke. J Neurol Neurosurg Psychiatry (2009) 1.40
Reporting clinical trials: full access to all of the data. Arch Neurol (2002) 1.39
Immunogenetic risk and protective factors for the idiopathic inflammatory myopathies: distinct HLA-A, -B, -Cw, -DRB1, and -DQA1 allelic profiles distinguish European American patients with different myositis autoantibodies. Medicine (Baltimore) (2006) 1.39
Definition and classification of hyperkinetic movements in childhood. Mov Disord (2010) 1.38
SUMOylation participates in induction of ischemic tolerance. J Neurochem (2009) 1.38
Prediction of human voluntary movement before it occurs. Clin Neurophysiol (2010) 1.36
Evaluation of essential tremor with multi-voxel magnetic resonance spectroscopy. Neurology (2003) 1.36
Short intracortical and surround inhibition are selectively reduced during movement initiation in focal hand dystonia. J Neurosci (2008) 1.35
Negative diffusion-weighted imaging after intravenous tissue-type plasminogen activator is rare and unlikely to indicate averted infarction. Stroke (2013) 1.33
Imaging neuroinflammation in Alzheimer's disease with radiolabeled arachidonic acid and PET. J Nucl Med (2008) 1.32
Research priorities in spasmodic dysphonia. Otolaryngol Head Neck Surg (2008) 1.31
Functional connectivity of cortical motor areas in the resting state in Parkinson's disease. Hum Brain Mapp (2010) 1.30
Genomewide scans in North American families reveal genetic linkage of essential tremor to a region on chromosome 6p23. Brain (2006) 1.29
The electric field induced in the brain by magnetic stimulation: a 3-D finite-element analysis of the effect of tissue heterogeneity and anisotropy. IEEE Trans Biomed Eng (2003) 1.28
A coil design for transcranial magnetic stimulation of deep brain regions. J Clin Neurophysiol (2002) 1.28
Elevated global SUMOylation in Ubc9 transgenic mice protects their brains against focal cerebral ischemic damage. PLoS One (2011) 1.28
Neural correlates of bimanual anti-phase and in-phase movements in Parkinson's disease. Brain (2010) 1.28
Modifications of the interactions in the motor networks when a movement becomes automatic. J Physiol (2008) 1.28
Screening questionnaire before TMS: an update. Clin Neurophysiol (2011) 1.27
Definition and classification of negative motor signs in childhood. Pediatrics (2006) 1.27
Placebo-controlled study of rTMS for the treatment of Parkinson's disease. Mov Disord (2006) 1.26
Changes in brain anatomy in focal hand dystonia. Ann Neurol (2004) 1.26
Movement disorders on YouTube--caveat spectator. N Engl J Med (2011) 1.25
Immunogenetic risk and protective factors for juvenile dermatomyositis in Caucasians. Arthritis Rheum (2006) 1.24
Excitability of the ipsilateral motor cortex during phasic voluntary hand movement. Exp Brain Res (2002) 1.24
How to assess motor impairment in writer's cramp. Mov Disord (2007) 1.24
Impaired intracortical inhibition in the primary somatosensory cortex in focal hand dystonia. Mov Disord (2008) 1.22
The etiopathogenesis of Parkinson disease and suggestions for future research. Part I. J Neuropathol Exp Neurol (2007) 1.21
Regional cerebral blood flow correlates of the severity of writer's cramp symptoms. Neuroimage (2004) 1.21
Effect of volitional inhibition on cortical inhibitory mechanisms. J Neurophysiol (2002) 1.21